/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
DISSEMINATION IN THE UNITED
STATES./
WINNIPEG, July 24, 2019 /CNW/ - Delta 9 Cannabis
Inc. ("Delta 9" or the "Company") (TSXV: DN)
(OTCQX: VRNDF) is pleased to announce that the Company's 8.5%
unsecured convertible debentures maturing July 17, 2022 (the "Convertible
Debentures") and common share purchase warrants expiring
July 17, 2022 (the "Warrants")
that were issued pursuant to the Company's short form prospectus
offering that closed on July 17,
2019, will commence trading on the TSX Venture Exchange on
the date hereof. The Convertible Debentures will trade under the
symbol "DN.DB" and the Warrants will trade under the symbol
"DN.WT.A".
The Company also wishes to announce that the Company's trading
symbol for its common shares has changed from "NINE" to "DN". The
trading symbol for the Company's other currently listed class of
common share purchase warrants has similarly changed from "NINE.WT"
to "DN.WT". The Company changed its trading symbol in order to
comply with the requirements of the TSX Venture Exchange (the
"Exchange") with regards to the listing of the Warrants.
Specifically, the trading symbol for the Warrants would have been
too many characters for the Exchange's trading system if the
Company maintained a four character trading symbol. For that
reason, the Company has changed from a four-character symbol (NINE)
to a two-character symbol (DN).
About Delta 9:
Delta 9 Cannabis is a vertically integrated cannabis company
focused on bringing the highest quality cannabis products to
market. Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc.,
is a licensed producer of medical marijuana pursuant to the ACMPR
and operates an 80,000 square foot production facility in
Winnipeg, Manitoba, Canada. Delta
9 owns and operates a chain of retail stores under the Delta 9
Cannabis Store brand. Delta 9's shares currently trade on the TSX
Venture Exchange under the symbol "DN" and on the OTC under the
symbol VRNDF.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Certain statements in this release are forward-looking
statements, which reflect the expectations of management regarding
the Company's future business plans and other matters.
Forward-looking statements consist of statements that are not
purely historical, including any statements regarding beliefs,
plans, expectations or intentions regarding the future.
No assurance can be given that any of the events anticipated
by the forward-looking statements will occur or, if they do occur,
what benefits the Company will obtain from them. Readers are urged
to consider these factors carefully in evaluating the
forward-looking statements contained in this news release and are
cautioned not to place undue reliance on such forward-looking
statements, which are qualified in their entirety by these
cautionary statements. These forward-looking statements are made as
of the date hereof and the Company disclaims any intent or
obligation to update publicly any forward-looking statements,
whether as a result of new information, future events or results or
otherwise, except as required by applicable securities
laws.
SOURCE Delta 9 Cannabis Inc.
